MSR61 Comparative Efficacy of Osilodrostat Versus Pasireotide Subcutaneous and Pasireotide Long-Acting Release for the Treatment of Cushing's Disease – A Patient-Level Data Indirect Treatment Comparison Using Propensity Score Weighting

Autor:	E Tyas, A Piacentini, M Hemstock, C Lilley, E Lebbink, S Matthijsse, F Schmidt, K Maman
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S530
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.04.1268
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4e92737770b57fb07bc4480ae1228432 https://doi.org/10.1016/j.jval.2022.04.1268 Zobrazit plný text záznamu Full Text from ScienceDirect